Expression Therapeutics, Inc. is a fully integrated clinical stage gene and cell therapy company based in Tucker, GA. They specialize in developing novel, potentially curative therapeutics for deadly childhood and adult genetic diseases, utilizing their scientific breakthrough in transgene bioengineering and protein engineering to optimize gene therapy for various target indications such as bleeding disorders, primary immunodeficiencies, and cancer.
With a multi-platform approach and a deep understanding of target diseases, Expression Therapeutics is a versatile drug development platform that is not limited to a specific technology. They have a state-of-the-art manufacturing facility capable of producing cGMP LV and AAV vectors, cell therapy products, and recombinant proteins, enabling them to expedite the development of their clinical programs.
Generated from the website